---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042926"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2024-10-29T23:59:59+00:00"
generated_at: "2026-05-30T08:50:19.067429+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# PURE Bioscience reports FY 2024 net loss of $3.4M; product sales up 4.5% to $1.955M

## Summary
- Net product sales $1.955M in FY 2024 vs $1.871M in FY 2023, up $84K (4.5%).
- Net loss improved to ($3.4M) from ($3.9M); net loss per share ($0.03) vs ($0.04).
- Net cash used in operations reduced to ($2.5M) from ($3.3M).
- Shifted strategy to distribution model; partnered with multiple distributors in fiscal 2024.
- R&D focused on Clean-in-Place solutions for food processing equipment sanitation.

## SEC filing metadata
- accession: 0001493152-24-042926
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2024-10-29T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315224042926/0001493152-24-042926-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315224042926/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042926
- JSON: https://secwatch.observer/filing/0001493152-24-042926.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042926.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.